Differential effects of 9-cis, 13-cis and all-trans retinoic acids on the neuronal differentiation of human neuroblastoma cells

NeuroReport

Volumn 14, Issue 15, 2003, Pages 1935-1939

  Chu, Patrick W K ^a   Cheung, William M W ^a   Kwong, Yok L ^a  

^a QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

Proliferation; RAR; RXR; Trk; Tyrosine hydroxylase

Indexed keywords

ANTIMITOTIC AGENT; ANTINEOPLASTIC AGENT; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; NERVE GROWTH FACTOR RECEPTOR; RETINOIC ACID; RETINOID X RECEPTOR; BETA GALACTOSIDASE; BIOLOGICAL MARKER; PROTEIN TYROSINE KINASE A; RETINOIC ACID RECEPTOR; TRANSCRIPTION FACTOR;

ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; CIS ISOMER; CONTROLLED STUDY; EXPERIMENTAL MODEL; HUMAN; HUMAN CELL; IN VITRO STUDY; NERVE CELL DIFFERENTIATION; NEUROBLASTOMA; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; TUMOR CELL LINE; BRAIN TUMOR; CELL DIFFERENTIATION; CELL DIVISION; CHEMISTRY; DRUG EFFECT; GENETIC TRANSFECTION; METABOLISM; NERVE CELL; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; STEREOISOMERISM; WESTERN BLOTTING;

BETA-GALACTOSIDASE; BIOLOGICAL MARKERS; BLOTTING, WESTERN; BRAIN NEOPLASMS; CELL DIFFERENTIATION; CELL DIVISION; CELL LINE, TUMOR; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; HUMANS; NEUROBLASTOMA; NEURONS; RECEPTOR, TRKA; RECEPTORS, RETINOIC ACID; RETINOID X RECEPTORS; SIGNAL TRANSDUCTION; STEREOISOMERISM; TRANSCRIPTION FACTORS; TRANSFECTION; TRETINOIN;

EID: 0642278084     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-200310270-00011     Document Type: Article

References (25)

1. Cheung WMW and Ip NY. Mol Cells 8, 496-502 (1998).
2. Warrell RP Jr, de The H, Wang ZY and Degos L. N Engl J Med 329, 177-189 (1993).
3. Chambon P. FASEB J 10, 940-954 (1996).
4. Cheung WMW, Hui WS, Chu PWK et al. FEBS Lett 486, 291-296 (2000).
5. Poongodi GL, Suresh N, Gopinath SC et al. J Biol Chem 277, 28200-28211 (2002).
6. Rabinovsky ED, Le WD and McManaman JL. J Neurosci 12, 171-179 (1992).
7. Nakagawara A, Arima-Nakagawara M, Scavarda NJ et al. N Engl J Med 328, 847-854 (1993).
8. Kogner P, Barbany G, Dominici C et al. Cancer Res 53, 2044-2050 (1993).
9. Alberts AS, Montminy M, Shenolikar S and Feramisco JR. Mol Cell Biol 14, 4398-4407 (1994).
10. Rideg K, Hirka G, Prakash K et al. Differentiation 56, 119-129 (1994).
11. Lee MK and Cleveland DW. Annu Rev Neurosci 19, 187-217 (1996).
12. Maurer JA and Wray S. J Neurosci 17, 4552-4561 (1997).
13. Aoyama M, Asai K, Shishikura T et al. Cancer Lett 164, 51-60 (2001).
14. Cheung B, Hocker JE, Smith SA et al. Biochem Biophys Res Commun 229, 349-354 (1996).
15. Lovat PE, Irving H, Annicchiarico-Petruzzelli M et al. Eur J Cancer 33, 2075-2080 (1997).
16. Spinella MJ, Kitareewan S, Mellado B et al. Oncogene 16, 2480-3471 (1998).
17. Cheung WMW, Chu PWK, Lung CH and Ip NY. J Neurochem 75, 34-40 (2000).
18. Rudolph D, Tafuri A, Gass P et al. Proc Natl Acad Sci USA 95, 4481-4486 (1998).
19. Weeber EJ and Sweatt JD. Neuron 33, 845-848 (2002).
20. Newton SS, Thome J, Wallace TL et al. J Neurosci 22, 10883-10890 (2002).
21. Zubenko GS, Hughes HB III, Maher BS et al. Am J Med Genet 114, 980-987 (2002).
22. Wysowski DK, Pitts M and Beitz J. N Engl J Med 344, 460 (2001).
23. Herdegen T and Leah JD. Brain Res Rev 28, 370-490 (1998).
24. Lemaigre FP, Ace CI and Green MR. Nucleic Acids Res 21, 2907-2911 (1993).
25. Chao MV. Nature Neurosci 4, 299-309 (2003).